Ilda Molloy, MD
Orthopaedic Surgery · New Haven, CTNPI 1285097378
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,297 of the $36,731 with a category attached, or 63.4%. Smith+Nephew accounts for 95.4% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $17,155, more than ten times the $27 reported in 2021.
Across 68 payments — averaging $540.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$35K
- Medical Device Business Services, Inc.$703
- Stryker$598
- Zimmer Biomet$174
- Davol Inc.$121
- Johnson & Johnson$105
What the payments were for
- Consulting fees$23,29763%
- Travel & lodging$5,15314%
- Food & beverage$3,2819%
- Education$5,00014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 48 | $35,030 |
| Medical Device Business Services, Inc. | 5 | $703 |
| Stryker | 9 | $598 |
| Zimmer Biomet | 3 | $174 |
| Davol Inc. | 2 | $121 |
| Johnson & Johnson | 1 | $105 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$84,924
- REAL INTELLIGENCE$27,157
- JOURNEY$14,398
- REDAPT$3,172
- POLARSTEM$2,576
- OR3O Dual Mobility$1,289
- Legion Revision$1,151
- RI.HIP NAVIGATION$1,151
- MAKO$250
- R3 ACETABULAR$138
- Persona$131
- Anthology$109
- Velys$105
How this compares
$36,731 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 28 | $1,203 |
| Diclofenac Sodium | 13 | $236 |
| Meloxicam | 45 | $136 |
| Oxycodone Hcl | 14 | $84 |
| Gabapentin | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Haven
- Peter WhangNew Haven$1.8M
- David FrumbergNew Haven$288K
- Michael LeslieNew Haven$85K
- Lee RubinNew Haven$72K
- John FulkersonNew Haven$67K
- Kristaps KeggiNew Haven$52K
- Daniel WizniaNew Haven$44K
- Dominick TuasonNew Haven$40K
- Michael MedveckyNew Haven$33K
- Francis LeeNew Haven$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.